Upcoming Webinars

ISRS delivers its 127th Webinar

Since we launched our webinar program in Oct 2016 we have delivered webinars on a fortnightly basis covering important topics related to intracranial and body SRS. These have become increasingly popular during the pandemic attracting hundreds of registrants. We have now completed our 120th webinar. This has all been made possible due to the generosity of the speakers who have given up their time to give high level lectures. Members can access recording of all of the webinars via our website: Access the library here.

Upcoming Webinars

International Practice Patterns and Clinical Target Volume Recommendations for SBRT for non-spine bone metastases

by Chia-Lin (Eric) TSENG, MD, FRCPC

Assistant Professor, University of Toronto
Department of Radiation Oncology
Sunnybrook Health Sciences Centre, Toronto, ON Canada

& Timothy NGUYEN, MD

Radiation Oncologist & Aspiring Medical Educator                                                                                                

London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University

July 21, 2022, 1:00PM BST

The use of SBRT for non-spine bone metastases (NSBM) continues to increase. In this webinar we will review recent literature on NSBM SBRT and provide an in depth discussion of two recent publications. The first focuses on international practice patterns for NSBM SBRT and the second provides CTV contouring recommendations in the same setting.


The Current Landscape of Spine Radiosurgery

by Kartik MANI, MD, PhD

Clinical Assistant Professor, Radiation Oncology 

Clinical Division Head Co-Chair

Spine Tumor Working Group Department of Radiation Oncology Department of Biomedical Informatics 

Stony Brook University Hospital, NY, USA

August 26, 2022, 1:00PM BST

Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are increasingly being utilized to treat metastatic patients, particularly those with a limited number of lesions (oligometastatic).  Patients with spinal metastases present unique challenges but are also benefiting significantly from this trend.  In this talk we will review the current evidence regarding the use of SRS/SBRT for spinal metastases, and discuss ongoing studies and future directions for multidisciplinary spine management.


Oligometastases to and from the lung – the role of SABR

by Shankar SIVA, MD

Radiation oncologist

Lung and Kidney Cancer; Stereotactic Ablative Body Radiotherapy (SABR)
Peter MacCallum Cancer Centre
Melbourne, Australia

September 26, 2022, 1:00PM BST

Oligometastatic disease is one of the most topical areas in radiation oncology in the present era. Several key trials have embedded the use of stereotactic ablative body radiotherapy (SABR) in the modern oncological armamentarium. However there are several key considerations for routine clinical practice; these include the optimal dose, sequencing, safety, combinations with systemic therapy and indications for the use of SABR in oligometastatic disease. This webinar will focus on two closely interrelated scenarios - the use of SABR in a) oligometastatic disease originating from lung cancer and b) pulmonary oligometastases. In this webinar, we will discuss the current state of play of evidence in the field, current controversies, and the future directions in these fields.